RCGH: a Comprehensive Array-based Genomic Profile Platform for Precision Medicine

Overview

Journal Bioinformatics

Publisher Oxford University Press

Specialty Biology

Date 2015 Dec 29

PMID 26708336

Citations 11

Authors

Frederic Commo

Justin Guinney

Charles Ferte

Brian Bot

Celine Lefebvre

Jean-Charles Soria

Fabrice Andre

Affiliations

Soon will be listed here.

Abstract

Unlabelled: We present rCGH, a comprehensive array-based comparative genomic hybridization analysis workflow, integrating computational improvements and functionalities specifically designed for precision medicine. rCGH supports the major microarray platforms, ensures a full traceability and facilitates profiles interpretation and decision-making through sharable interactive visualizations.

Availability And Implementation: The rCGH R package is available on bioconductor (under Artistic-2.0). The aCGH-viewer is available at https://fredcommo.shinyapps.io/aCGH_viewer, and the application implementation is freely available for installation at https://github.com/fredcommo/aCGH_viewer

Contact: frederic.commo@gustaveroussy.fr

Supplementary Information: Supplementary data are available at Bioinformatics online.

Citing Articles

Exploiting NRF2-ARE pathway activation in papillary renal cell carcinoma.

Angori S, Lakshminarayanan H, Banaei-Esfahani A, Muhlbauer K, Bolck H, Kallioniemi O Int J Cancer. 2024; 156(7):1457-1469.

PMID: 39707614 PMC: 11789458. DOI: 10.1002/ijc.35311.

Genomics to select treatment for patients with metastatic breast cancer.

Andre F, Filleron T, Kamal M, Mosele F, Arnedos M, Dalenc F Nature. 2022; 610(7931):343-348.

PMID: 36071165 DOI: 10.1038/s41586-022-05068-3.

Identification of a Gene-Expression-Based Surrogate of Genomic Instability during Oral Carcinogenesis.

Truchard E, Bertolus C, Martinez P, Thomas E, Saintigny P, Foy J Cancers (Basel). 2022; 14(3).

PMID: 35159101 PMC: 8834046. DOI: 10.3390/cancers14030834.

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer.

Zarczynska I, Gorska-Arcisz M, Cortez A, Kujawa K, Wilk A, Skladanowski A Cells. 2021; 10(12).

PMID: 34943871 PMC: 8699485. DOI: 10.3390/cells10123363.

Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges.

Song K, Minami J, Huang A, Dehkordi S, Lomeli S, Luebeck J Cancer Discov. 2021; 12(4):1046-1069.

PMID: 34930786 PMC: 9192483. DOI: 10.1158/2159-8290.CD-20-0936.

References

Olshen A, Venkatraman E, Lucito R, Wigler M . Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004; 5(4):557-72. DOI: 10.1093/biostatistics/kxh008. View

Willenbrock H, Fridlyand J . A comparison study: applying segmentation to array CGH data for downstream analyses. Bioinformatics. 2005; 21(22):4084-91. DOI: 10.1093/bioinformatics/bti677. View

Laurent-Puig P, Cayre A, Manceau G, Buc E, Bachet J, Lecomte T . Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. J Clin Oncol. 2009; 27(35):5924-30. DOI: 10.1200/JCO.2008.21.6796. View

Mermel C, Schumacher S, Hill B, Meyerson M, Beroukhim R, Getz G . GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011; 12(4):R41. PMC: 3218867. DOI: 10.1186/gb-2011-12-4-r41. View

Commo F, Ferte C, Soria J, Friend S, Andre F, Guinney J . Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology. Ann Oncol. 2014; 26(3):582-8. PMC: 4343013. DOI: 10.1093/annonc/mdu582. View